These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7528558)

  • 21. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.
    Pilebro B; Johansson R; Damber L; Damber JE; Stattin P
    Scand J Urol Nephrol; 2003; 37(3):210-2. PubMed ID: 12775278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine].
    Bourel M; Ardaillou R;
    Bull Acad Natl Med; 2003; 187(5):985-95. PubMed ID: 14979060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PSA testing in Austria: induced morbidity and saved mortality.
    Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
    Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Increased incidence of prostatic cancer. The significance of prostate-specific antigen].
    Otnes B; Harvei S; Fosså SD
    Tidsskr Nor Laegeforen; 1996 Jun; 116(15):1795-9. PubMed ID: 8693464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PSA screening and prostate cancer mortality.
    Perron L; Moore L; Bairati I; Bernard PM; Meyer F
    CMAJ; 2002 Mar; 166(5):586-91. PubMed ID: 11898936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Timely screening routines for prostatic cancer by Norwegian physicians].
    Fosså SD; Eri LM
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3572-6. PubMed ID: 10563174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer incidence rates have started to decrease in central Italy.
    Crocetti E; Ciatto S; Buzzoni C; Zappa M
    J Med Screen; 2010; 17(1):50-1. PubMed ID: 20356946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
    Schröder FH; Raaijmakers R; Postma R; van der Kwast TH; Roobol MJ
    J Urol; 2005 Aug; 174(2):489-94; discussion 493-4. PubMed ID: 16006878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial. PSA screening and low risk prostate cancer, what's going on? are we shooting the messenger?
    Martínez-Salamanca JI
    Arch Esp Urol; 2012 Mar; 65(2):209-14. PubMed ID: 22414449
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate cancer screening.
    Houston SA
    Sci Am; 1994 Aug; 271(2):9. PubMed ID: 7520599
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostate cancer screening.
    Sweet MD
    Sci Am; 1994 Aug; 271(2):9. PubMed ID: 7520600
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostate cancer screening.
    Hahn DL
    Sci Am; 1994 Aug; 271(2):9. PubMed ID: 7520598
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemoprevention of prostate cancer: breakthroughs and controversies.
    Kim J
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1517-22. PubMed ID: 20942621
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostate-specific antigen in screening for prostate cancer.
    Mayer FJ; Crawford ED
    West J Med; 1994 Feb; 160(2):168. PubMed ID: 7512780
    [No Abstract]   [Full Text] [Related]  

  • 39. Beyond PSA: will future biomarker tests be better?
    Mayo Clin Health Lett; 2009 Aug; 27(8):4. PubMed ID: 19757525
    [No Abstract]   [Full Text] [Related]  

  • 40. Evolution and immediate future of US screening guidelines.
    Greene KL; Punnen S; Carroll PR
    Urol Clin North Am; 2014 May; 41(2):229-35. PubMed ID: 24725485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.